Der Report
Verifizierte Nachrichten zu Finanzierung, Hauptsitzen und Führungskräften der innovativsten Unternehmen der Welt
104 Berichte und es werden mehr
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Easol Raises $30M Series A Extension for Experience Commerce
Easol announced a $30 million Series A extension, made up of $20 million in equity and a $10 million Viola Credit debt facility, and launched its Teammates AI agent tool for experience businesses.
Stand Raises $70M Series C at $1B Valuation
Stand, which insures homes in catastrophe-exposed regions, raised a $70 million Series C at a $1 billion valuation led by Saga Ventures.
KONST Raises $30M Series B for AI Data Center Buildout
KONST raised a $30 million Series B led by ADATA Technology to scale its AI data center buildout across Asia and advance its Token Factory strategy.
Fortastra Raises $30M Series A for On-Orbit Security Spacecraft
Fortastra raised a $30 million Series A led by First In to scale maneuverable spacecraft for on-orbit security.
Biolevate Raises €30M Series A for Life Sciences Automation
Biolevate raised a €30 million Series A co-led by RAISE France and Orange Ventures to expand evidence-grade automation for regulated life sciences operations.
Buildots Raises $130M in Round Led by O.G. Venture Partners
Buildots announced a $130M funding round led by O.G. Venture Partners, bringing total funds raised to $297 million.
PatientIQ Raises $30M Series C for Patient Outcomes Intelligence
PatientIQ raised a $30 million Series C led by Hughes and Company to deepen its presence across existing specialties and health systems, expand its real-world evidence platform for medical device and life sciences companies, and build a direct-to-patient commerce experience.
NovaGo Therapeutics Raises $30M Series B for Spinal Cord Injury Study
NovaGo Therapeutics raised a $30 million Series B led by Neurimmune and Pureos Bioventures to advance a proof-of-concept study in acute spinal cord injury.
9 Berichte angezeigt • Seite 1 • Kategorie: all
Bleiben Sie dem Markt voraus
Erhalten Sie wöchentliche Insights direkt in Ihren Posteingang. Kein Spam, nur Intelligence.